Atria Wealth Solutions, Inc. Bristol Myers Squibb CO Transaction History
Atria Wealth Solutions, Inc.
- $8.79 Billion
- Q2 2024
A detailed history of Atria Wealth Solutions, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 167,176 shares of BMY stock, worth $8.65 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
167,176
Previous 195,453
14.47%
Holding current value
$8.65 Million
Previous $10.6 Million
34.5%
% of portfolio
0.08%
Previous 0.12%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.66 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.21 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.73 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.86 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.06 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $110B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...